Advisors Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Advisors Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-8,154	Closed	-$588K	–	1556
2020 Q4	$588K	Sell	8,154 -4,998	-38%	-$262K	0.01%	918
2020 Q3	$599K	Sell	13,152 -208	-2%	-$8.7K	0.01%	864
2020 Q2	$604K	Sell	13,360 -191	-1%	-$8.56K	0.01%	844
2020 Q1	$522K	Sell	13,551 -740	-5%	-$34.1K	0.01%	810
2019 Q4	$662K	Sell	14,291 -201	-1%	-$8.7K	0.01%	902
2019 Q3	$590K	Sell	14,492 -356	-2%	-$15.4K	0.01%	929
2019 Q2	$715K	Buy	14,848 +3,094	+26%	+$163K	0.01%	898
2019 Q1	$736K	Buy	11,754 +9,343	+388%	+$642K	0.01%	941
2018 Q4	$144K	Buy	+2,411	New	+$145K	﹤0.01%	1277

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Advisors Asset Management's BEAT Position: Q1 2021 in Review

Advisors Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 8,154 shares — an estimated $588K sold.

Advisors Asset Management first reported a position in BEAT in Q4 2018 and held it in 9 quarters. The position peaked at $736K in Q1 2019. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Advisors Asset Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Advisors Asset Management sold 8,154 BioTelemetry, Inc. shares in Q1 2021, an estimated $588K.
Advisors Asset Management first reported a position in BioTelemetry, Inc. in Q4 2018 and held it in 9 quarters.
Advisors Asset Management's BioTelemetry, Inc. position peaked at $736K in Q1 2019.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Advisors Asset Management's 13F filing for Q1 2021, filed 7 May 2021.